Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study.

Walter, Roland B; Medeiros, Bruno C; Gardner, Kelda M; Orlowski, Kaysey F; Gallegos, Leonel; Scott, Bart L; Hendrie, Paul C; Estey, Elihu H.
Haematologica; 99(1): 54-9, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24142996